Continuous Levodopa Delivery with an Intraoral Micropump System: An Open‐Label Pharmacokinetics and Clinical Study
C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Karl Kieburtz(Beth Israel Deaconess Medical Center), Fabrizio Stocchi(San Raffaele University of Rome), Ephraim Heller(SynAgile (United States)), José Á. Obeso(Biomedical Research Networking Center on Neurodegenerative Diseases), Andrew McGarry(Cooper Medical School of Rowan University), Margherita Torti, Cornelia Kamp(University of Rochester), Julie Kennedy, Mika Leinonen, Deborah McIntyre(Luxembourg Institute of Health), Rejko Krüger(Centre Hospitalier de Luxembourg), Michele Matarazzo(HM Hospitales)
Cited by 11
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
|Nature reviews. Neuroscience|2010|1.1k